AXIN2 germline mutations are rare in familial melanoma

Genes Chromosomes and Cancer

Volumn 50, Issue 5, 2011, Pages 370-373

  Pedace, Lucia ^a   Castiglia, Daniele ^b   De Simone, Paola ^c   Castori, Marco ^a   De Luca, Naomi ^b   Amantea, Ada ^c   Binni, Francesco ^a   Majore, Silvia ^a   Cozzolino, Angela Maria ^a   De Bernardo, Carmelilia ^a   Zambruno, Giovanna ^b   Catricalà, Caterina ^c   Grammatico, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

AXIN2 GENE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CHROMOSOME 17Q; FAMILIAL CANCER; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERM LINE; HETEROZYGOSITY; HUMAN; ITALY; LETTER; MELANOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; ALLELIC IMBALANCE; BETA CATENIN; COHORT STUDIES; CYTOSKELETAL PROTEINS; FEMALE; GENE FREQUENCY; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HUMANS; MALE; MELANOMA; PEDIGREE; POLYMORPHISM, GENETIC; ROME; WNT PROTEINS; YOUNG ADULT;

EID: 79952377093     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20855     Document Type: Letter

References (17)

1. Binni F, Antigoni I, De Simone P, Majore S, Silipo V, Crisi A, Amantea A, Pacchiarini D, Castori M, De Bernardo C, Catricalà C, Grammatico P. 2010. Novel and recurrent p14 mutations in Italian familial melanoma. Clin Genet 77: 581-586.
2. Callahan N, Modesto A, Meira R, Seymen F, Patir A, Vieira AR. 2009. Axis inhibition protein 2 (AXIN2) polymorphisms and tooth agenesis. Arch Oral Biol 54: 45-49.
3. Castiglia D, Bernardini S, Alvino E, Pagani E, De Luca N, Falcinelli S, Pacchiarotti A, Bonmassar E, Zambruno G, D'Atri S. 2008. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma. Genes Chromosomes Cancer 47: 614-624.
4. Emine GG, Ergum P, Hatice P, Yavuz S. 2009. Strong association between lung cancer and the AXIN2 polymorphism. Mol Med 2: 1029-1035.
5. Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A. 2000. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene 27: 537-545.
6. Kanzaki H, Ouchida M, Hanafusa H, Yano M, Suzuki H, Aoe M, Imai K, Shimizu N, Nakachi K, Shimizu K. 2006. Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population. Int J Mol Med 18: 279-288.
7. Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH. 2009. Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. 2009. Hum Pathol 40: 58-64.
8. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A. 1998. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273: 10823-10826.
9. Koch A, Hrychyk A, Hartmann W, Waha A, Mikeska T, Waha A, Schüller U, Sörensen N, Berthold F, Goodyer CG, Wiestler OD, Birchmeier W, Behrens J, Pietsch T. 2007. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas. Int J Cancer 15: 284-291.
10. Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, Pirinen S, Nieminen P. 2004. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 74: 1043-1050.
11. Lejeune S, Guillemot F, Triboulet JP, Cattan S, Mouton C; PAFNORD Group, Porchet N, Manouvrier S, Buisine MP. 2006. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat 27: 1064.
12. Majore S, De Simone P, Crisi A, Eibenschutz L, Binni F, Antigoni I, De Bernardo C, Catricalà C, Grammatico P. 2008. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma. Pigment Cell Melanoma Res 21: 209-211.
13. Peterlongo P, Howe LR, Radice P, Sala P, Hong YJ, Hong SI, Mitra N, Offit K, Ellis NA. 2005. Germline mutations of AXIN2 are not associated with nonsyndromic colorectal cancer. Hum Mutat 25: 498-500.
14. Petersen B, Petersen TN, Andersen P, Nielsen M, Lundegaard C. 2009. A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Struct Bio 9:51 doi:10.1186/1472-6807-9-51.
15. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. 2002. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 18: 4863-4871.
16. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hählen K, Hasle H, Licht JD, Gelb BD. 2003. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34: 148-150.
17. Wu R, Zhai Y, Fearon ER, Cho KR. 2001. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61: 8247-8255.